Three-dimensional analysis with MRI and PET of the size, shape, and function of the thalamus in the schizophrenia spectrum

American Journal of Psychiatry

Volumn 156, Issue 8, 1999, Pages 1190-1199

  Hazlett, Erin A ^a   Buchsbaum, Monte S ^b   Byne, William ^b   Wei, Tse Chung ^b   Spiegel Cohen, Jacqueline ^b   Geneve, Craig ^b   Kinderlehrer, Rayzel ^b   Haznedar, M Mehmet ^b   Shihabuddin, Lina ^b   Siever, Larry J ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN FUNCTION; BRAIN MAPPING; BRAIN METABOLISM; BRAIN SIZE; CLINICAL ARTICLE; FEMALE; HUMAN; LEARNING TEST; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERSONALITY DISORDER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCHIZOPHRENIA; TASK PERFORMANCE; THALAMUS;

ADULT; BRAIN; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MEMORY; SCHIZOPHRENIA; SCHIZOTYPAL PERSONALITY DISORDER; THALAMIC NUCLEI; THALAMUS; TOMOGRAPHY, EMISSION-COMPUTED; VERBAL LEARNING;

EID: 0032866654     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Buchsbaum MS, Someya T, Teng CY, Abel L, Chin S, Najafi A, Haier RJ, Wu J, Bunney WE Jr: PET and MRI of the thalamus in never-medicated patients with schizophrenia. Am J Psychiatry 1996; 153:191-199
2. Andreasen NC, Arndt S, Swayze V II, Cizadlo T, Flaum M, O'Leary D, Ehrhardt JC, Yuh WTC: Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. Science 1994; 266:294-298
3. McGhie A, Chapman J: Disorders of attention and perception in early schizophrenia. Br J Med Psychol 1961; 34:102-116
4. Braff D: Information processing and attention dysfunctions in schizophrenia. Schizophr Bull 1993; 19:233-259
5. Carlsson M, Carlsson A: Interactions between glutamatergic and monoaminergic systems within the basal ganglia. Trends Neurosci 1990; 13:272-276
6. Bogerts B, Falkai P, Greve B, Schneider T, Pfeiffer U: The neuropathology of schizophrenia. J Hirnforsch 1993; 34:193-203
7. Bogerts B: The temporolimbic system theory of positive schizophrenic symptoms. Schizophr Bull 1997; 23:423-435
8. Pakkenberg B: Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch Gen Psychiatry 1990; 47:1023-1028
9. Pakkenberg B: The volume of the mediodorsal thalamic nucleus in treated and untreated schizophrenics. Schizophr Res 1992; 7:95-100
10. Blennow K, Davidsson P, Gottfries C, Ekman R, Helig M: Synaptic degeneration in thalamus in schizophrenia. Lancet 1996;348:692-693
11. Danos P, Bauman B, Bernstein H, Franz M, Stauch R, Northoff G, Krell D, Falkai P, Bogerts B: Schizophrenia and anteroventral thalamic nucleus. Psychiatry Res Neuroimaging 1998;82:1-10
12. Casanova M, Carosella N, Kleinman J: Neuropathological findings in a suspected case of childhood schizophrenia. J Neuropsychiatry 1990; 2:313-318
13. Goldman-Rakic P, Porrino L: The primate mediodorsal (MD) nucleus and its projection to the frontal lobe. J Comp Neurol 1985;242:535-560
14. Andreasen NC: The role of the thalamus in schizophrenia. Can J Psychiatry 1997; 42:27-33
15. Andreasen NC, Ehrhardt JC, Swayze VW II, Alliger RJ, Yuh WT, Cohen G, Ziebell S: Magnetic resonance imaging of the brain in schizophrenia: the pathophysiologic significance of structural abnormalities. Arch Gen Psychiatry 1990; 47:35-44
16. Flaum M, Swayze VW II, O'Leary DS, Yuh WTC, Ehrhardt JC, Arndt SV, Andreasen NC: Effects of diagnosis, laterality, and gender on brain morphology in schizophrenia. Am J Psychiatry 1995; 152:704-714
17. Jones E: Cortical development and thalamic pathology in schizophrenia. Schizophr Bull 1997; 23:483-501
18. Seidman L, Faraone S, Goldstein J, Goodman J, Kremen W, Matsuda G, Hoge E, Kennedy D, Makris N, Caviness V, Tsuang M: Reduced subcortical brain volumes in nonpsychotic siblings of schizophrenic patients. Am J Med Genet 1997; 74: 507-514
19. Frazier J, Giedd J, Hamburger S, Albus K, Kaysen D, Vaituzis A, Rajapakse J, Lenane M, McKenna K, Jacobsen L, Gordon C, Breier A, Rapoport J: Brain anatomic magnetic resonance imaging in childhood-onset schizophrenia. Arch Gen Psychiatry 1996;53:617-624
20. Rapoport JL: Child psychiatry comes of age: growing sophistication, evolving strategies (editorial). Am J Psychiatry 1997; 154:1043-1045
21. Corey-Bloom J, Jernigan T, Archibald S, Harris MJ, Jeste DV: Quantitative magnetic resonance imaging of the brain in late-life schizophrenia. Am J Psychiatry 1995; 152:447-449
22. Portas C, Goldstein J, Shenton M, Hokama H, Wible C, Fischer I, Kikinis R, Donnino R, Jolesz F, McCarley R: Volumetric evaluation of the thalamus in schizophrenic male patients using magnetic resonance imaging. Biol Psychiatry 1998; 43: 649-659
23. Resnick S, Gur R, Alavi A, Gur R, Reivich M: Positron emission tomography and subcortical glucose metabolism in schizophrenia. Psychiatry Res 1988; 24:1-11
24. Jacobsen LK, Giedd M, Castellanos FX, Vaituzis AC, Hamburger SD, Kumra S, Lenane MC, Rapoport JL: Progressive reduction of temporal lobe structures in childhood-onset schizophrenia. Am J Psychiatry 1998; 155:678-685
25. Wiesel F, Wik G, Sjögren I, Blomqvist G, Greitz T, Stone-Elander S: Regional brain glucose metabolism in drug free schizophrenic patients and clinical correlates. Acta Psychiatr Scand 1987; 76:628-641
26. Wik G, Wiesel F, Sjögren I, Blomqvist G, Greitz T, Stone-Elander S: Effects of sulpiride and chlorpromazine on regional cerebral glucose metabolism in schizophrenic patients as determined by emission tomography. Psychopharmacology (Berl) 1989; 97:309-318
27. Tamminga C, Thaker G, Buchanan R, Kirkpatrick B, Alphs L, Chase T, Carpenter W: Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch Gen Psychiatry 1992; 49:522-530
28. Buchsbaum MS, Wu JC, DeLisi LE, Holcomb HH, Hazlett E, Cooper-Langston K, Kessler R: Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects. Biol Psychiatry 1987; 66:479-494
29. Kling AS, Metter EJ, Riege WH, Kuhl DE: Comparison of PET measurement of local brain glucose metabolism and CAT measurement of brain atrophy in chronic schizophrenia and depression. Am J Psychiatry 1986; 143:175-180
30. Siegel BV Jr, Buchsbaum MS, Bunney WE Jr, Gottschalk LA, Haier RJ, Lohr JB, Lottenberg S, Najafi A, Nuechterlein KH, Potkin SG, Wu J: Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients. Am J Psychiatry 1993; 150:1325-1336
31. Szechtman H, Nahmias C, Garnett S, Firnau G, Brown G, Kaplan R, Cleghorn J: Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia. Arch Gen Psychiatry 1988; 45:523-532
32. Szymanski S, Gur R, Gallacher F, Mozley L, Gur R: Vulnerability to tardive dyskinesia development in schizophrenia. Neuropsychopharmacology 1996; 15:567-575
33. Carpenter M, Sutin J: Human Neuroanatomy. Baltimore, Williams & Wilkins, 1983
34. Choi D, Sudarsky L, Schacter S, Biber M, Burke P: Medial thalamic hemorrhage with amnesia. Arch Psychol 1983; 40:611-613
35. Squire LR, Moore RY: Dorsal thalamic lesions in a noted case of human memory dysfunction. Ann Neurol 1979; 6:503-506
36. Crosson B, Hughes C: Role of the thalamus in language. Schizophr Bull 1987; 13:605-621
37. Siever L, Silverman J, Horvath T, Klar H, Coccaro E, Keefe R, Pinkham L, Rinaldi P, Mohs R, Davis K: Increased morbid risk for schizophrenia-related disorders in relatives of schizotypal personality disordered patients. Arch Gen Psychiatry 1990; 47:634-640
38. Andreasen NC, Flaum M, Arndt S: The Comprehensive Assessment of Symptoms and History (CASH): an instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry 1992; 49:615-623
39. Overall JE, Gorham DR: The Brief Psychiatric Rating Scale. Psychol Rep 1962; 10:799-812
40. Endicott J, Spitzer RL: A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 1978; 35:837-844
41. Stangl D, Pfohl B, Zimmerman M: A structured interview for DSM-III personality disorders: a preliminary report. Arch Gen Psychiatry 1985; 42:591-596
42. Shihabuddin L, Buchsbaum M, Hazlett E, Haznedar M, Harvey P, Newman A, Schnur D, Spiegel-Cohen J, Wei T, Machac J, Knesaurek K, Vallabhojosula S, Biren M, Ciaravolo T, Luu-Hsia C: Dorsal striatal size, shape, and metabolic rate in neuroleptic-naive and previously medicated schizophrenic patients performing a verbal learning task. Arch Gen Psychiatry 1998;55:235-243
43. Delis D, Kramer J, Kaplan E, Ober B: California Verbal Learning Test. San Antonio, Psychological Corp, 1987
44. Pelizzari C, Chen G, Spelbring D, Weichselbaum R, Chen C: Accurate three-dimensional registration of CT, PET, and/or MR images of the brain. J Comput Assist Tomogr 1989; 13: 20-26
45. Bartko J: On various intraclass correlation reliability coefficients. Psychol Bull 1976; 83:762-765
46. Matsui T, Hirano A: An Atlas of the Human Brain for Computerized Tomography. Tokyo, Igaku-Shoin, 1978
47. Bartels P, Subach J: Significance probability mappings and automated interpretation of complex pictorial scenes, in Digital Processing of Biomedical Imagery. Edited by Preston E, Onoe M. New York, Academic Press, 1976, pp 101-114
48. Friston KJ, Frith C, Liddle P, Frackowiak R: Plastic transformation of PET images. J Comput Assist Tomogr 1991; 15:634-659
49. Arndt S, Cizadlo T, Andreasen NC, Heckel D, Gold S, O'Leary DS: Tests for comparing images based on randomization and permutation methods. J Cereb Blood Flow 1996; 16:1271-1279
50. Haznedar MM, Buchsbaum MS, Metzger M, Solimando A, Spiegel-Cohen J, Hollander E: Anterior cingulate gyrus volume and glucose metabolism in autistic disorder. Am J Psychiatry 1997; 154:1047-1050
51. Tamminga CA, Thaker GK, Buchanan R, Kirkpatrick B, Alphs LD, Chase TN, Carpenter WT: Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch Gen Psychiatry 1992; 49:522-530
52. Portas C, Goldstein J, Shenton M, Hokama H, Wible C, Fischer I, Kikinis R, Donnino R, Jolesz F, McCarley R: Volumetric evaluation of the thalamus in schizophrenic male patients using magnetic resonance imaging. Biol Psychiatry 1998; 43: 649-659
53. Buchsbaum MS, Yang S, Hazlett E, Siegel BV Jr, Germans M, Haznedar M, O'Flaithbheartaigh S, Wei T, Silverman J, Siever LJ: Ventricular volume and asymmetry in schizotypal personality disorder and schizophrenia assessed with magnetic resonance imaging. Schizophr Res 1997; 27:45-53
54. Haznedar MM, Buchsbaum MS, Luu C, Hazlett EA, Siegel BV Jr, Lohr J, Wu J, Haier RJ, Bunney WE Jr: Decreased anterior cingulate gyrus metabolic rate in schizophrenia. Am J Psychiatry 1997; 154:682-684
55. Fuster J: The Prefrontal Cortex. New York, Raven Press, 1989
56. Jones E: The Thalamus. New York, Plenum, 1985
57. Van Buren J, Borke R: Variations and Cerebral Connections of the Thalamus. New York, Springer-Verlag, 1972
58. Rose J, Woolsey C: The orbitofrontal cortex and its connections with the mediodorsal nucleus in rabbit, sheep, and cat. Association for Research in Nervous and Mental Disease Proceedings 1948; 27:210-282
59. Uylings H, Van Eden C: Qualitative and quantitative comparison of the prefrontal cortex in rat and in primates, including humans. Prog Brain Res 1990; 85:31-62
60. Andreasen NC, O'Leary DS, Flaum M, Nopoulos P, Watkins GL, Boles Ponto LL, Hichwa RD: Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naive patients. Lancet 1997; 349:1730-1734
61. Buchsbaum MS, Tang CY, Peled S, Gudbjartsson H, Lu D, Hazlett EA, Downhill J, Haznedar M, Fallon JH, Atlas SW: MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia. Neuroreport 1998; 9:425-430
62. Katz M, Buchsbaum MS, Siegel BV, Wu J, Haier RJ, Bunney WE: Correlational patterns of cerebral glucose metabolism in never-medicated schizophrenics. Neuropsychobiology 1996; 33:1-11
63. Hazlett EA, Buchsbaum MS, Haznedar MM, Singer MB, Schnur DB, Jimenez EA, Buchsbaum BR, Troyer BT: Prefrontal cortex glucose metabolism and startle eyeblink modification abnormalities in unmedicated schizophrenia patients. Psychophysiology 1998; 35:186-198
64. Chakos MH, Lieberman JA, Bilder RM, Borenstein M, Lerner G, Bogerts B, Wu H, Kinon B, Ashtari M: Increase in caudate nuclei volume of first-episode schizophrenic patients taking antipsychotic drugs. Am J Psychiatry 1994; 151:1430-1436
65. Oke A, Putz C, Adam R, Bird E: Neuroleptic treatment is an unlikely cause of elevated dopamine in thalamus of schizophrenic subjects. Psychiatry Res Neuroimaging 1992; 45: 203-208